在衰竭中出现出血.

G Remuzzi¹

¹Mario Negri Institute for Pharmacological Research, Bergamo, Italy.

Lancet (London, England)

|May 28, 1988

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.

The Cochrane database of systematic reviews·2004

Same author

Genetics of rare diseases of the kidney: learning from mouse models.

Cytogenetic and genome research·2004

Same author

Nephrotoxic aspects of cyclosporine.

Transplantation proceedings·2004

Same author

Proteinuria and its consequences in renal disease.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2004

Same author

Pharmacological and clinical profile of valsartan.

Drugs of today (Barcelona, Spain : 1998)·2004

Same author

[Thrombotic microangiopathy].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2003

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

在衰竭中出现出血.

相关概念视频

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.

Genetics of rare diseases of the kidney: learning from mouse models.

Nephrotoxic aspects of cyclosporine.

Proteinuria and its consequences in renal disease.

Pharmacological and clinical profile of valsartan.

[Thrombotic microangiopathy].

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

在衰竭中出现出血.

相关概念视频

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.

Genetics of rare diseases of the kidney: learning from mouse models.

Nephrotoxic aspects of cyclosporine.

Proteinuria and its consequences in renal disease.

Pharmacological and clinical profile of valsartan.

[Thrombotic microangiopathy].

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.